Skip to content

Insider · CIK 0001263499

DUGAN RICHARD W

Reports to the SEC for 3 companies · BOALSBURG, PA

Transactions

50

Companies

3

Filings

10

CIK

0001263499

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-06-04VNDAVanda Pharmaceuticals Inc.A Award—
2025-06-05VNDAVanda Pharmaceuticals Inc.A Award—
2024-05-17VNDAVanda Pharmaceuticals Inc.A Award—
2024-05-17VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2023-06-08VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2023-06-08VNDAVanda Pharmaceuticals Inc.A Award—
2022-06-16VNDAVanda Pharmaceuticals Inc.A Award—
2022-06-16VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2022-05-31VNDAVanda Pharmaceuticals Inc.S Sale−$64.1K
2022-05-31VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2022-05-31VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$62.3K
2021-06-10VNDAVanda Pharmaceuticals Inc.A Award—
2021-06-10VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2021-02-16VNDAVanda Pharmaceuticals Inc.S Sale−$107K
2021-02-16VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2021-02-16VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$107K
2020-06-11VNDAVanda Pharmaceuticals Inc.A Award—
2020-06-11VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2020-05-28VNDAVanda Pharmaceuticals Inc.S Sale−$112K
2020-05-28VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion—
2020-05-28VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$111K
2019-08-26VNDAVanda Pharmaceuticals Inc.S Sale−$223K
2019-08-26VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$222K
2019-08-26VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion—
2019-06-13VNDAVanda Pharmaceuticals Inc.A Award—
2019-06-13VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2018-06-13VNDAVanda Pharmaceuticals Inc.A Award—
2018-06-13VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2018-03-19VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2018-03-19VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$74.7K
2017-06-15VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2017-06-15VNDAVanda Pharmaceuticals Inc.A Award—
2016-06-16VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2015-06-18VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2015-03-09VNDAVanda Pharmaceuticals Inc.S Sale−$51.3K
2015-03-09VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion+$50K
2015-03-09VNDAVanda Pharmaceuticals Inc. · Nonqualified Stock Option (Right to Buy)M Exercise/Conversion—
2013-06-20VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2012-06-14VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2011-06-16VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award—
2010-06-03VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)A Award—
2009-08-27VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)A Award—
2009-06-23MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award—
2005-06-02CORNERSTONE THERAPEUTICS INCOption to Purchase Common StockA Award—
2005-05-25MiddleBrook Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award—
2004-10-21MiddleBrook Pharmaceuticals, Inc.P Purchase+$287
2004-10-21MiddleBrook Pharmaceuticals, Inc.P Purchase+$2,958.3
2004-10-21MiddleBrook Pharmaceuticals, Inc.P Purchase+$3,949.8
2004-10-21MiddleBrook Pharmaceuticals, Inc.P Purchase+$7,200
2004-06-16CORNERSTONE THERAPEUTICS INCOptions to PurchaseA Award—

Recent filings

10